John Armitage's CME Position Overview
John Armitage (via Egerton Capital (Uk) Llp) currently holds 1.2M shares of CME Group Inc. (CME) worth $320.12 M, representing 3.38% of the portfolio. First purchased in 2020-Q4, this medium-term investment has been held for 20 quarters.
Based on 13F filings, John Armitage has maintained a strategic position in CME, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 765.8K shares. Largest reduction occurred in Q3 2025, reducing 338.1K shares.
Analysis based on 13F filings available since 2013 Q2
John Armitage's CME Group (CME) Holding Value Over Time
Track share changes against reported price movement
Quarterly CME Group (CME) Trades by John Armitage
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2020 | +450,249 | New Buy | 450,249 | $182.05 |
| Q1 2021 | -449 | Reduce 0.10% | 449,800 | $204.23 |
| Q2 2021 | -449,800 | Sold Out | 449,800 | $0.00 |
| Q4 2024 | +964,421 | New Buy | 964,421 | $232.23 |
| Q1 2025 | +765,773 | Add 79.40% | 1.73 M | $265.29 |
| Q2 2025 | -207,258 | Reduce 11.98% | 1.52 M | $275.62 |
| Q3 2025 | -338,148 | Reduce 22.20% | 1.18 M | $270.19 |
John Armitage's CME Group Investment FAQs
John Armitage first purchased CME Group Inc. (CME) in Q4 2020, acquiring 450,249 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Armitage has held CME Group Inc. (CME) for 20 quarters since Q4 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Armitage's largest addition to CME Group Inc. (CME) was in Q4 2024, adding 964,421 shares worth $223.97 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, John Armitage's firm, Egerton Capital (Uk) Llp, owns 1,184,788 shares of CME Group Inc. (CME), valued at approximately $320.12 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, CME Group Inc. (CME) represents approximately 3.38% of John Armitage's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Armitage's peak holding in CME Group Inc. (CME) was 1,730,194 shares, as reported at the end of Q1 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.